Contributing to global tuberculosis control through innovative research and training:
From Bench to Bedside and Beyond.

Read More

Where we Work

Events

TB Clinical and Epidemiology Lunch Meeting

Time: Every Thursday at 12:20pm - 1:20pm

Cancer Research Building 2, 1550 Orleans St, 1M.13
Baltimore, MD

Click for More Information

Updates

Treatment for preventing tuberculosis in...

IMPORTANCE:  Three months of a once-weekly combination of rifapentine and isoniazid for treatment of latent tuberculosis...

Read More

C-reactive protein (CRP), interferon...

Objective: The association between pre-antiretroviral (ART) inflammation and immune activation and risk for incident...

Read More

The epidemiological advantage of preferential...

Tuberculosis (TB) remains disproportionately concentrated among the poor, yet known determinants of TB reactivation may fail to...

Read More

Costs and Consequences of Using Interferon-γ...

There is growing concern that interferon-γ release assays (IGRAs) are being used off-label for the diagnosis of active...

Read More

Nuclear imaging: a powerful novel approach...

Nearly 20 years after the World Health Organization declared tuberculosis (TB) a global public health emergency, TB...

Read More